Big Health Care Companies Are Undervalued
Botox Maker Allergan Sold to AbbVie for $63B
CFOs on the Move: Week Ending Nov. 2
The Companies That Pay the Slowest
To Stop Tax Inversions, Obama Could Dust Off Old Law
Another Tax Inversion Deal in the Works
Treasury Stance Regardless, Another Tax-Inversion Deal Pops Up